OverviewChartNewsTraderScreen

Morgan Stanley Call 230 PGR 21.03.../  DE000MG100J8  /

Stuttgart
05/08/2024  17:52:35 Chg.- Bid10:17:34 Ask10:17:34 Underlying Strike price Expiration date Option type
1.27EUR - 1.41
Bid Size: 2,500		 1.47
Ask Size: 2,500		 Progressive Corporat... 230.00 USD 21/03/2025 Call
TeleTrader 07:59 Aramco's Q2 net income down 3.2% to $29.1 billion
TeleTrader 29/07 Putin congratulates Maduro on election victory
TeleTrader 27/07 G20 agrees to work together to tax billionaires
TeleTrader 25/07 Nikki Haley not surprised by Biden's presidential race exit
TeleTrader 15/07 Syrians head to polls for parliamentary elections
TeleTrader 13/07 Progressive Caucus meets with Biden
TeleTrader 11/07 Peskov: NATO nears Russia's borders, could provoke response
TeleTrader 08/07 Lula proud of France's fight against 'extremism'
TeleTrader 05/07 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 25/06 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 25/06 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 24/06 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 24/06 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 24/06 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 19/06 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 18/06 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 14/06 Progressive Reports May 2024 Results
GlobeNewswire 13/06 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 12/06 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 11/06 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 10/06 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...